TRISHA KLEMAN: Open Payments
NPI 1184125775 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 47 payments from 11 companies in 2025. Trend: 2023 $403 · 2024 $362 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $142 |
| ABBVIE INC. | 6 | $89 |
| Lilly USA, LLC | 3 | $54 |
| PFIZER INC. | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| Exact Sciences Corporation | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Dexcom, Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
Products named: CAPLYTA, Wegovy, VRAYLAR, MOUNJARO, Ozempic, JARDIANCE, Cologuard Collection Kit, XIFAXAN.
Industry payments across OH — which companies pay providers there.
